These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 15951019

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C.
    Lim JH, Lee YN, Kim YS, Kim SG, Jeong SW, Jang JY, Kim HS, Lee SH, Park TK.
    Korean J Hepatol; 2011 Mar; 17(1):61-5. PubMed ID: 21494079
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C.
    Kasahara A, Hiraide A, Tomita N, Iwahashi H, Imagawa A, Ohguro N, Yamamoto S, Mita E, Hayashi N.
    J Gastroenterol; 2004 Nov; 39(11):1106-9. PubMed ID: 15580406
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Concurrent antiphospholipid syndrome and cutaneous [corrected] sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C.
    Shinohara MM, Davis C, Olerud J.
    J Drugs Dermatol; 2009 Sep; 8(9):870-2. PubMed ID: 19746680
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of chronic viral hepatitis].
    Pedersen C, Pedersen CR.
    Ugeskr Laeger; 2008 Jun 09; 170(24):2137-40. PubMed ID: 18565297
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [New therapeutic possibilities in chronic hepatitis C].
    Criblez DH.
    Praxis (Bern 1994); 2000 Mar 09; 89(11):450-3. PubMed ID: 10758732
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vogt-Koyanagi-Harada disease in patients with chronic hepatitis C.
    Touitou V, Bodaghi B, Cassoux N, Tran TH, Rao NA, Cacoub P, LeHoang P.
    Am J Ophthalmol; 2005 Nov 09; 140(5):949-52. PubMed ID: 16310490
    [Abstract] [Full Text] [Related]

  • 16. Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis.
    Tran HA, Malcolm Reeves GE, Gibson R, Attia JR.
    J Gastroenterol Hepatol; 2009 Jul 09; 24(7):1163-8. PubMed ID: 19682190
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Autoimmune thrombocytopenia induced by PEG-IFN-alpha plus ribavirin in hepatitis C.
    Demirturk N, Cevik F, Demirdal T, Aykin N, Aslan V.
    Platelets; 2006 Aug 09; 17(5):340-3. PubMed ID: 16928608
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.